Zobrazeno 71 - 80
of 1 035
pro vyhledávání: ''
Autor:
Tsunekazu Mizushima, Chu Matsuda, Masaki Mori, Ichiro Takemasa, Naotsugu Haraguchi, Hidekazu Takahashi, Junichi Nishimura, Taroh Satoh, Daisuke Sakai, Toshihiro Kudo, Tsuyoshi Hata, Taishi Hata, Yuichiro Doki
Publikováno v:
Oncology. 97:211-216
Objectives: The aim of this study was to determine the recommended dose (RD) of capecitabine combined with oxaliplatin and irinotecan (XELOXIRI) as a neoadjuvant chemotherapy in patients with locally advanced rectal cancer. Method: Patients received
Autor:
Nicolò Bassi, Francesco Ferrara, Stefano Benvenuti, Marta Campo Dell'Orto, Marco Massani, Andromachi Kotsafti, Angelo Paolo Dei Tos, Luca Maria Saadeh, Marco Scarpa, Anna Pozza, Luisa Toffolatti, Cesare Ruffolo
Publikováno v:
European Surgical Research. 60:186-195
Background: Interferon gamma (IFNγ) and tumor necrosis factor-related weak inducer of apoptosis (TWEAK) molecules seem to have a potential effect on angiogenic factors such as vascular endothelial growth factor (VEGF). The aim of this study was to a
Autor:
Giusi Santangelo, Carolina Maria Sassu, Innocenza Palaia, Giorgia Perniola, Federica Tomao, Antonella Giancotti, Angela Musella, Violante Di Donato, Anna Di Pinto, Pierluigi Benedetti Panici
Publikováno v:
Oncology. 97:306-310
Background: Chemotherapy at the end of life is a complex and challenging problem in medical oncology. Patients affected by ovarian cancer (OC) often experience a chronicization and slow progression of their disease, and chemotherapy is proposed until
Autor:
Mariela A. Blum Murphy, Irene Thomas, Jane E. Rogers, Elizabeth Sanders, Jaffer A. Ajani, Fatemeh G. Amlashi, Namita Shanbhag, Lianchun Xiao, Elena Elimova
Publikováno v:
Oncology. 96:252-258
Background: The RAINBOW trial established ramucirumab combined with paclitaxel as a second-line option in metastatic gastric and gastroesophageal junction (GEJ) adenocarcinoma. Ramucirumab was given on days 1 and 15 with paclitaxel on days 1, 8, and
Publikováno v:
Oncology Research and Treatment. 42:431-439
Background: Cancer-related fatigue (CRF) is one of the most troubling symptoms of cancer patients during chemotherapy, and no gold standard for the treatment of CRF has been established. Objective: This study aimed to examine the effects of the Badua
Autor:
Do Hoon Lim, Joon-Ho Lee, Filippo Pietrantonio, Seung Tae Kim, Federica Morano, Min Gew Choi, Won Ki Kang, Kyoung-Mee Kim, Giovanni Fucà, Jae Moon Bae, Tae Sung Sohn, Se Hoon Park, Maria Di Bartolomeo, Sung Kim, Jiyeong An, Rosalba Miceli, Jeeyun Lee, Alessandra Raimondi
Publikováno v:
Oncology. 97:38-43
Background: Caucasian patients with microsatellite instability (MSI)-high gastric cancer (GC) may have better prognosis but worse outcomes. Objective: Here we explored the prognostic role of MSI in Asian patients. Methods: This post hoc analysis comp
Publikováno v:
Oncology Research and Treatment. 42:269-274
Background: Pegylated liposomal doxorubicin (PEG-LD) has a comparable efficacy but a distinct toxicological profile compared with free doxorubicin. The use of PEG-LD and cyclophosphamide followed by docetaxel regimen as neoadjuvant chemotherapy has n
Autor:
Kazuo Kobayashi, Takeshi Aoyama, Kensei Yamaguchi, Mitsukuni Suenaga, Takashi Yokokawa, Takeru Wakatsuki, Kenichi Suzuki, Toshihiro Hama, Kazuyoshi Kawakami, Erika Sugiyama, Hitoshi Sato
Publikováno v:
Oncology. 96:200-206
Purpose: Hand-foot skin reaction (HFSR) can deteriorate quality of life in patients receiving regorafenib. Cutaneous toxicity is a main adverse effect of multikinase inhibitors and has also been associated with clinical outcome. This study assessed t
Autor:
Antonio Pontoriero, Salvatore Lopes, Antonio Potami, Giovanna Messina, Pietro Delia, Michele Pisana, Santa De Salvo, Giuseppe Sansotta, Stefano Pergolizzi, Giuseppe Iatì
Publikováno v:
Oncology Research and Treatment. 42:212-218
Background: Radiotherapy treatment for cervical cancer (CC) often induces side effects, including inflammation, dryness, dyspareunia. Considering its key role in the healing process, hyaluronic acid (HA) could be useful for the completion of radiothe
Autor:
Masatoshi Tanaka, Toshi Abe, Naoki Kamachi, Mika Nomiyama, Ryoko Kuromatsu, Masahito Nakano, Takashi Niizeki, Hiroyuki Suzuki, Hideki Iwamoto, Takuji Torimura, Etsuyo Ogo, Manabu Satani, Syusuke Okamura, Hironori Koga, Shigeo Shimose, Miwa Sakai, Yu Noda, Tomotake Shirono
Publikováno v:
Oncology. 96:192-199
Aim: Prognosis of hepatocellular carcinoma (HCC) with macrovascular invasion (MVI) is extremely poor. However, proper therapeutic strategies have not been established yet. The purpose of this study is to identify the effects of external beam radiatio